Grantor Acknowledgments

ACC.16 Grantor Acknowledgments

Supported by an educational grant from:

  • Abbott Vascular
  • Actelion Pharmaceuticals US, Inc.
  • Amarin Pharma Inc.
  • Amgen Inc.
  • Astellas
  • AstraZeneca LP
  • Biosense Webster, Inc.
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
  • Boston Scientific Corporation
  • Bristol Myers Squibb and Pfizer, Inc.
  • Cordis Corporation
  • GE HEALTHCARE INC.
  • Medtronic, Inc.
  • Merck & Co.
  • Novartis Pharmaceuticals Corporation
  • St. Jude Medical, Inc.
  • The Medicines Company
  • Thoratec Corporation
  • United Therapeutics Corporation
  • *Grantors as of March 9, 2016

    ACC.16 Clinical Focus Session Grantor Acknowledgments

    Dyslipidemia Combo-Therapy: A Framework for Clinical Decision-Making
    Supported by an educational grant from:

  • Amgen Inc.
  • Merck & Co.
  • Pfizer, Inc.
  • Sanofi US and Regeneron Pharmaceuticals
  • The Future of Bleeding Management: Is Your Team Ready?
    Supported by an educational grant from:

  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Bristol Myers Squibb and Pfizer, Inc.
  • The Great “K” Debate: Optimization of Heart Failure Pharmacotherapy
    Supported by an educational grant from:

  • ZS Pharma, Inc.
  • The Nuts and Bolts of Heart Failure Therapies: Pharmacological Case Challenges
    Supported by an educational grant from:

  • Amgen Inc.
  • Novartis Pharmaceuticals Corporation
  • Valve Therapy in Tomorrowland
    Supported by an educational grant from:

  • Abbott Vascular
  • Edwards Lifesciences LLC
  • Medtronic, Inc.
  • *Grantors as of March 11, 2016

    Advertisement

    ACC Logo
    ACC.17 on Social Media:
          
    2016 American College of Cardiology Foundation. Visit ACC.org
    Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Contact Us